INVO logo

INVO Bioscience (INVO) CAPEX

Annual CAPEX

$444.70 K
+$432.00 K+3401.57%

December 31, 2023

Summary

Performance

1-Year Change

+3401.57%

3-Year Change

+400.22%

5-Year Change

+2192.27%

15-Year Change

-

INVO CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$454.60 K
INVO annual capital expenditures is currently -2.18% below its historical high of $454.60 thousand

3-Year Low

$12.70 K
INVO annual capital expenditures is currently +3401.57% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
INVO next annual earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Annual FCF

-$5.20 M
INVO annual free cash flow is -$5.20 million

Annual CFO

-$4.76 M
INVO annual cash flow from operations is -$4.76 million

Annual CFI

-$2.49 M
INVO annual cash flow from investing activities is -$2.49 million

Annual CFF

$7.39 M
INVO annual cash flow from financing activities is $7.39 million

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

INVO Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$747.40 K
INVO quarterly capital expenditures is currently at an all-time high

3-Year Low

-$328.10 K
INVO quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

Quarterly FCF

-$640.81 K
INVO quarterly free cash flow is -$640.81 thousand

Quarterly CFO

-$640.81 K
INVO quarterly cash flow from operations is -$640.81 thousand

Quarterly CFI

$0.00
INVO quarterly cash flow from investing activities is $0.00

Quarterly CFF

$169.46 K
INVO quarterly cash flow from financing activities is $169.46 thousand

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

INVO TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$813.70 K
INVO TTM capital expenditures is currently at an all-time high

3-Year Low

-$315.20 K
INVO TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOcash flowmetrics:

TTM FCF

-$3.25 M
INVO TTM free cash flow is -$3.25 million

TTM CFO

-$3.07 M
INVO TTM cash flow from operations is -$3.07 million

TTM CFI

$4100.00
INVO TTM cash flow from investing activities is $4100.00

TTM CFF

$2.48 M
INVO TTM cash flow from financing activities is $2.48 million

INVO CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3401.6%--
3 y3 years+400.2%--
5 y5 years+2192.3%--

INVO CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.2%-97.1%
5 y5-year-2.2%-97.1%
alltimeall time-2.2%-97.1%

INVO Bioscience CAPEX History

DateAnnualQuarterlyTTM
Jun 2024
-
$55.10 K(+10.9%)
$288.00 K(-41.7%)
Mar 2024
-
$49.70 K(-33.7%)
$494.40 K(+11.2%)
Dec 2023
$444.70 K(+3401.6%)
$75.00 K(-30.7%)
$444.70 K(+20.3%)
Sep 2023
-
$108.20 K(-58.6%)
$369.60 K(+39.8%)
Jun 2023
-
$261.50 K(<-9900.0%)
$264.40 K(+1965.6%)
Dec 2022
$12.70 K(-97.2%)
-$100.00(-103.3%)
$12.80 K(-104.1%)
Sep 2022
-
$3000.00(-9.1%)
-$315.20 K(-173.4%)
Jun 2022
-
$3300.00(-50.0%)
$429.20 K(-0.7%)
Mar 2022
-
$6600.00(-102.0%)
$432.30 K(-4.9%)
Dec 2021
$454.60 K
-$328.10 K(-143.9%)
$454.70 K(-44.1%)
Sep 2021
-
$747.40 K(>+9900.0%)
$813.70 K(+760.1%)
Jun 2021
-
$6400.00(-77.9%)
$94.60 K(+1.9%)
DateAnnualQuarterlyTTM
Mar 2021
-
$29.00 K(-6.1%)
$92.80 K(+4.4%)
Dec 2020
$88.90 K(-22.5%)
$30.90 K(+9.2%)
$88.90 K(+53.3%)
Sep 2020
-
$28.30 K(+515.2%)
$58.00 K(-27.1%)
Jun 2020
-
$4600.00(-81.7%)
$79.60 K(-12.9%)
Mar 2020
-
$25.10 K(>+9900.0%)
$91.40 K(-20.3%)
Dec 2019
$114.70 K(+491.2%)
$0.00(-100.0%)
$114.70 K(0.0%)
Sep 2019
-
$49.90 K(+204.3%)
$114.70 K(+77.0%)
Jun 2019
-
$16.40 K(-66.1%)
$64.80 K(+33.9%)
Mar 2019
-
$48.40 K(+528.6%)
$48.40 K(+208.3%)
Dec 2018
$19.40 K(+23.6%)
-
-
Dec 2016
$15.70 K(-78.8%)
$7700.00(-3.8%)
$15.70 K(+96.3%)
Sep 2016
-
$8000.00
$8000.00
Dec 2008
$73.90 K
-
-

FAQ

  • What is INVO Bioscience annual capital expenditures?
  • What is the all time high annual CAPEX for INVO Bioscience?
  • What is INVO Bioscience annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for INVO Bioscience?
  • What is the all time high TTM CAPEX for INVO Bioscience?

What is INVO Bioscience annual capital expenditures?

The current annual CAPEX of INVO is $444.70 K

What is the all time high annual CAPEX for INVO Bioscience?

INVO Bioscience all-time high annual capital expenditures is $454.60 K

What is INVO Bioscience annual CAPEX year-on-year change?

Over the past year, INVO annual capital expenditures has changed by +$432.00 K (+3401.57%)

What is the all time high quarterly CAPEX for INVO Bioscience?

INVO Bioscience all-time high quarterly capital expenditures is $747.40 K

What is the all time high TTM CAPEX for INVO Bioscience?

INVO Bioscience all-time high TTM capital expenditures is $813.70 K